Pioneer Holding reports revenue decline, profit halves in first half 2025

Shanghai Pioneer Holding Ltd. reported revenue of RMB647.3 million for the six months ended June 30, 2025, a 20.9% decrease from RMB818.0 million in the same period last year. Gross profit also fell by 13.6% to RMB303.0 million, down from RMB350.5 million. Net profit for the period was RMB45.8 million, a substantial 48.1% decline from RMB88.3 million in the first half of 2024. Basic earnings per share were RMB0.04, a 50.0% reduction from RMB0.08 previously.

The decrease in revenue was primarily driven by a 14.3% drop in pharmaceutical product sales and a 12.4% decrease in medical device sales through comprehensive marketing and promotion services. Additionally, products sold via channel management services saw a 58.0% revenue decrease, largely due to the digestion of inventory following an agreement non-renewal with Alcon in August 2024.

Despite the financial contraction, the group declared an interim dividend of HK$0.064 per ordinary share, totaling HK$80,477,000, payable on October 20, 2025. The company also saw its cash and cash equivalents increase to RMB173.6 million as of June 30, 2025, up from RMB103.6 million at the end of 2024.